HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

What Is The Prognosis Of Hürthle Cell Adenoma And How Can One Confirm The Percentage Of Conversion Into Malignancy?

default
Posted on Fri, 4 Feb 2022
Question: Kindly confirm the prognosis of Hurthle cell adenoma and percentage of conversion into malignancy
doctor
Answered by Dr. Monish De (1 hour later)
Brief Answer:

Chances of conversion into malignancy is 20 to 45%

Detailed Answer:

Hi

I have gone through your reports

Hurthle cell adenoma is a rare benign tumor

Typically such a mass is removed because it is not easy to predict whether it will transform into the malignant counterpart a subtype of follicular thyroid cancer called a Hurthle cell carcinoma but overall prognosis is good and overall survival rate is 10 years

Chances of conversion into malignancy is 20 to 45%

Regards

Dr Monish De

Oncologist
Note: For further queries related to kidney problems Click here.

Above answer was peer-reviewed by : Dr. Remy Koshy
doctor
Answered by
Dr.
Dr. Monish De

Oncologist

Practicing since :2004

Answered : 2229 Questions

premium_optimized

The User accepted the expert's answer

Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
What Is The Prognosis Of Hürthle Cell Adenoma And How Can One Confirm The Percentage Of Conversion Into Malignancy?

Brief Answer: Chances of conversion into malignancy is 20 to 45% Detailed Answer: Hi I have gone through your reports Hurthle cell adenoma is a rare benign tumor Typically such a mass is removed because it is not easy to predict whether it will transform into the malignant counterpart a subtype of follicular thyroid cancer called a Hurthle cell carcinoma but overall prognosis is good and overall survival rate is 10 years Chances of conversion into malignancy is 20 to 45% Regards Dr Monish De Oncologist